This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Molina (MOH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
UnitedHealth (UNH) Q3 Earnings and Revenues Beat, Guidance Up
by Sapna Bagaria
UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.
Humana to Provide Florida's Retirees With Medicare Plans
by Zacks Equity Research
Humana's (HUM) Medicare plans to help the State of Florida Medicare-eligible retirees and their eligible dependents achieve better health outcomes.
MEDNAX (MD) to Sell MedData for Focusing on Core Business
by Zacks Equity Research
MEDNAX (MD) to divest its billing services business for streamlining its operations.
Is Molina (MOH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?
by Zacks Equity Research
Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.
The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina
by Zacks Equity Research
The Zacks Analyst Blog Highlights: KB Home, Beazer, American Electric and Molina
Humana's New Plans to Complement VA Healthcare Coverage
by Zacks Equity Research
Humana's (HUM) Humana Honor Medicare Advantage plans to help veterans get better health outcomes. It will also complement the VA plan.
4 Stocks to Win Big as Powell Hints at Another Rate Cut
by Tirthankar Chakraborty
Fed Chair Powell leaves the door open for another rate cut in October as jobs growth last month was not as robust as expected and trade concerns continue to impede economic growth.
Centene's Carolina Complete Health Wins Medicaid Contract
by Zacks Equity Research
Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.
Humana's (HUM) Medicare Business Aids, High Costs Persist
by Zacks Equity Research
Humana's (HUM) revenues and membership gain on strong Medicare business. However, high expenses hurt.
Economic Worries Buoy Rate-Cut Hopes: 5 Winners
by Tirthankar Chakraborty
Worries about a probable economic downturn have increased this week, fueling rate-cut hopes. CME's Fedwatch indicator showed that almost 90.3% of investors are now expecting another rate cut.
Tenet Healthcare's Strategic Initiatives Aid, Revenues Drag
by Zacks Equity Research
Strategic divestitures bode well for Tenet Healthcare's (THC) growth. However, depleting revenues is a lingering woe.
Molina (MOH) Stock Moves -0.22%: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $109.48, marking a -0.22% move from the previous day.
Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?
by Zacks Equity Research
Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.
Molina Healthcare Enters Oversold Territory
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Are Investors Undervaluing Molina (MOH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Molina (MOH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $116.21, marking a +1.44% move from the previous day.
UnitedHealth to Offer Medicare Advantage Plan in Bay Area
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Cigna Expands Health Care Exchange Offerings to New Markets
by Zacks Equity Research
Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.
Here is How Wall Street Reacts to Fed's Easing Cycle
by Tirthankar Chakraborty
Since we are expecting "insurance cuts", where a slowdown are imminent but the economy isn't in a recession, the benchmark S&P 500 is still very much poised to come up with healthy gains in the near term.
Humana and Seniorlink to Serve Medicare Advantage Members
by Zacks Equity Research
Humana (HUM) collaborates with Seniorlink to unveil Virtual Care Team pilot for offering its Medicare Advantage members an improved healthcare management.